Spots Global Cancer Trial Database for sorafenib (nexavar)
Every month we try and update this database with for sorafenib (nexavar) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer | NCT00607438 | Breast Cancer | Paclitaxel Albu... Sorafenib (Nexa... | 18 Years - | Veeda Oncology | |
| Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma | NCT00887107 | Thyroid Cancer | Sorafenib (nexa... | 18 Years - 80 Years | Leiden University Medical Center | |
| Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer | NCT00619996 | Prostate Cancer | Sorafenib (Nexa... Docetaxel | - | Italian Trial in Medical Oncology | |
| Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma | NCT00498836 | Malignant Melan... | CP-4055 Sorafenib (Nexa... | 18 Years - | Clavis Pharma | |
| A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer | NCT00607438 | Breast Cancer | Paclitaxel Albu... Sorafenib (Nexa... | 18 Years - | Veeda Oncology | |
| Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma | NCT00901901 | Carcinoma, Hepa... | Sorafenib (Nexa... Erlotinib (Tarc... Placebo | 18 Years - | Bayer | |
| Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor | NCT00922584 | Non-Small Cell ... | sorafenib (Nexa... | 18 Years - | Chinese Society of Lung Cancer | |
| Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer | NCT00619996 | Prostate Cancer | Sorafenib (Nexa... Docetaxel | - | Italian Trial in Medical Oncology | |
| A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer | NCT00607438 | Breast Cancer | Paclitaxel Albu... Sorafenib (Nexa... | 18 Years - | Veeda Oncology | |
| Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy | NCT01159327 | Small Cell Lung... | Sorafenib | 18 Months - | National Cancer Center, Korea | |
| Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas | NCT01338857 | neurofibromatos... Recurrent or Pr... Recurrent or Pr... | Sorafenib (Nexa... | 2 Years - | NYU Langone Health | |
| Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas | NCT01338857 | neurofibromatos... Recurrent or Pr... Recurrent or Pr... | Sorafenib (Nexa... | 2 Years - | NYU Langone Health | |
| Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma | NCT00498836 | Malignant Melan... | CP-4055 Sorafenib (Nexa... | 18 Years - | Clavis Pharma | |
| Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma | NCT00901901 | Carcinoma, Hepa... | Sorafenib (Nexa... Erlotinib (Tarc... Placebo | 18 Years - | Bayer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
